MRES

Institute of Biomedical Research Corp. MRES

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MRES FAMDF HMTXF TELIF PRVCF ARUXF HOOK GVDI IMEXF PBSV
6M -76.17 % -90.00 % 12.54 % 75.34 % -13.28 % -77.75 % 12.23 % -20.00 % 0.00 % 22.12 %
YTD -73.71 % -96.25 % -6.97 % 18.30 % 11.17 % -70.33 % -54.36 % -16.67 % 0.00 % 10.96 %
1Y 6.25 % -96.05 % 65.31 % 3.36 % 47.18 % -82.20 % -75.62 % 166.67 % -99.17 % -1.57 %
3Y -71.82 % -97.27 % -35.43 % 18.52 % 23.45 % -70.33 % -92.39 % 900.00 % -99.94 % -28.20 %
5Y -64.83 % -93.18 % 1 139.83 % -31.90 % -29.13 % -92.58 % -99.08 % 48.15 % -99.98 % -54.79 %
10Y -74.50 % -96.51 % 16 903.43 % -31.90 % 339.74 % -97.83 % -99.36 % 33.33 % -100.00 % -35.76 %
From the beginning -99.99 % -99.01 % 6 164.42 % -31.90 % 339.74 % -99.43 % -99.36 % -100.00 % -100.00 % -51.18 %

Dividend

Acrux Limited

Pharma-Bio Serv, Inc.